Gemfibrozil
NDC 71209-008, Gemfibrozil, tablet, from Cadila Pharmaceuticals Limited.
- Product NDC
- 71209-008
- Status
- Listed
- Labeler
- Cadila Pharmaceuticals Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203266
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71209-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GEMFIBROZIL600 mg/1
Pharmacologic classes
PPAR alpha [CS]; Peroxisome Proliferator Receptor alpha Agonist [EPC]; Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71209-008-03 | 71209000803 | 60 TABLET in 1 BOTTLE (71209-008-03) |
| 71209-008-08 | 71209000808 | 180 TABLET in 1 BOTTLE (71209-008-08) |
| 71209-008-10 | 71209000810 | 500 TABLET in 1 BOTTLE (71209-008-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0b50849a-66b6-4e8f-9f45-5425a875d366
Use it
Look up 71209-008 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71209-008 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71209-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.